Livzon Microsphere Technology

Livzon Microsphere Technology is a specialized biopharmaceutical company and a subsidiary of Livzon Pharmaceutical Group, focused on the development of high-end long-acting injectable formulations. The company utilizes its proprietary microsphere technology platform to develop sustained-release versions of complex drugs, primarily targeting oncology, endocrinology, and psychiatry. Its lead commercial product, Leuprorelin Acetate Microspheres, is a market leader in China for the treatment of prostate cancer and endometriosis. The company's robust pipeline includes late-stage candidates such as triptorelin and octreotide microspheres, which aim to improve patient adherence by significantly reducing injection frequency. Livzon Microsphere maintains state-of-the-art manufacturing facilities in Zhuhai that comply with international GMP standards. By bridging the gap between innovative drug delivery and clinical needs, the company has established itself as a leader in the Chinese microsphere formulation market.